Podcasts about cdad

LLEGAMOS A BUENOS AIRES!!! Función: 3 de octubre 2024 Recinto: Sala Pablo Neruda, Paseo La Plaza. Dirección: Av. Corrientes 1660, Cdad. Autónoma de Buenos Aires, Argentina. Hora: 22:15 hrs Tickets : https://www.plateanet.com/obra/26676?obra=FELIPE-AVELLO&paso=inicio #FelipeAvello en vivo desde Gran Arena Monticello 2024 Extractos del show realizado el 14 de septiembre del 2024, en Gran Arena Monticello. Si quieres ver este capitulo en video, lo podrás encontrar en nuestro canal de Youtube https://www.youtube.com/@FelipeAvelloOficial Capítulo: https://www.youtube.com/watch?v=_txheXherxI También nos puedes encontrar en: Instagram: https://instagram.com/felipeavellooficial?igshid=MzRlODBiNWFlZA== TikTok: https://www.tiktok.com/@felipeavellooficial?_t=8g1JYWMrkRB&_r=1 Para próximos shows y compra de entradas visita: https://felipeavello.cl/

Nos vemos en Argentina!!! Función: 3 de octubre 2024 Recinto: Sala Pablo Neruda, Paseo La Plaza. Dirección: Av. Corrientes 1660, Cdad. Autónoma de Buenos Aires, Argentina. Hora: 22:15 hrs Tickets : https://www.plateanet.com/obra/26676?obra=FELIPE-AVELLO&paso=inicio #FelipeAvello en vivo desde Centro Mori Recoleta 2024 Extractos del show realizado el 8 de agosto del 2024. Si quieres ver este capitulo en video, lo podrás encontrar en nuestro canal de Youtube https://www.youtube.com/@FelipeAvelloOficial Capítulo: https://www.youtube.com/watch?v=zndajho0hUw&t= También nos puedes encontrar en: Instagram: https://instagram.com/felipeavellooficial?igshid=MzRlODBiNWFlZA== TikTok: https://www.tiktok.com/@felipeavellooficial?_t=8g1JYWMrkRB&_r=1 Para próximos shows y compra de entradas visita: https://felipeavello.cl

Nos vemos en Argentina!!! Función: 3 de octubre 2024 Recinto: Sala Pablo Neruda, Paseo La Plaza. Dirección: Av. Corrientes 1660, Cdad. Autónoma de Buenos Aires, Argentina. Hora: 22:15 hrs Tickets : https://www.plateanet.com/obra/26676?obra=FELIPE-AVELLO&paso=inicio #FelipeAvello en vivo desde Palermo teatro-bar 2024 Extractos del show 2 realizado el 31 de agosto del 2024. Si quieres ver este capitulo en video, lo podrás encontrar en nuestro canal de Youtube https://www.youtube.com/@FelipeAvelloOficial Capítulo: https://www.youtube.com/watch?v=tvqJXdiIBUI También nos puedes encontrar en: Instagram: https://instagram.com/felipeavellooficial?igshid=MzRlODBiNWFlZA== TikTok: https://www.tiktok.com/@felipeavellooficial?_t=8g1JYWMrkRB&_r=1 Para próximos shows y compra de entradas visita: https://felipeavello.cl/

Nos vemos en Argentina!!! Función: 3 de octubre 2024 Recinto: Sala Pablo Neruda, Paseo La Plaza. Dirección: Av. Corrientes 1660, Cdad. Autónoma de Buenos Aires, Argentina. Hora: 22:15 hrs Tickets : https://www.plateanet.com/obra/26676?obra=FELIPE-AVELLO&paso=inicio #FelipeAvello en vivo desde Centro Mori Recoleta 2024 Extractos de los shows realizados el 1 de agosto y 4 de septiembre del 2024. Si quieres ver este capitulo en video, lo podrás encontrar en nuestro canal de Youtube https://www.youtube.com/@FelipeAvelloOficial Capítulo: https://www.youtube.com/watch?v=FpbIL2lK-jA También nos puedes encontrar en: Instagram: https://instagram.com/felipeavellooficial?igshid=MzRlODBiNWFlZA== TikTok: https://www.tiktok.com/@felipeavellooficial?_t=8g1JYWMrkRB&_r=1 Para próximos shows y compra de entradas visita: https://felipeavello.cl/

Nos vemos en Argentina!!! Función: 3 de octubre 2024 Recinto: Sala Pablo Neruda, Paseo La Plaza. Dirección: Av. Corrientes 1660, Cdad. Autónoma de Buenos Aires, Argentina. Hora: 22:15 hrs Tickets : https://www.plateanet.com/obra/26676?obra=FELIPE-AVELLO&paso=inicio #FelipeAvello en vivo desde Palermo teatro-bar 2024 Extractos del show realizado el 7 de septiembre del 2024. Si quieres ver este capitulo en video, lo podrás encontrar en nuestro canal de Youtube https://www.youtube.com/@FelipeAvelloOficial Capítulo: https://www.youtube.com/watch?v=aKkA1hXH2MM También nos puedes encontrar en: Instagram: https://instagram.com/felipeavellooficial?igshid=MzRlODBiNWFlZA== TikTok: https://www.tiktok.com/@felipeavellooficial?_t=8g1JYWMrkRB&_r=1 Para próximos shows y compra de entradas visita: https://felipeavello.cl/

Nos vemos en Argentina!!! Función: 3 de octubre 2024 Recinto: Sala Pablo Neruda, Paseo La Plaza. Dirección: Av. Corrientes 1660, Cdad. Autónoma de Buenos Aires, Argentina. Hora: 22:15 hrs Tickets : https://www.plateanet.com/obra/26676?obra=FELIPE-AVELLO&paso=inicio #FelipeAvello en vivo desde Centro Mori Recoleta 2024 Extractos del show 2 realizado el pasado 1 de Agosto del 2024. Si quieres ver este capitulo en video, lo podrás encontrar en nuestro canal de Youtube https://www.youtube.com/@FelipeAvelloOficial Capítulo: https://www.youtube.com/watch?v=WJ-lEcZVC5I También nos puedes encontrar en: Instagram: https://instagram.com/felipeavellooficial?igshid=MzRlODBiNWFlZA== TikTok: https://www.tiktok.com/@felipeavellooficial?_t=8g1JYWMrkRB&_r=1 Para próximos shows y compra de entradas visita: https://felipeavello.cl/

Nos vemos en Argentina!!! Función: 3 de octubre 2024 Recinto: Sala Pablo Neruda, Paseo La Plaza. Dirección: Av. Corrientes 1660, Cdad. Autónoma de Buenos Aires, Argentina. Hora: 22:15 hrs Tickets : https://www.plateanet.com/obra/26676?obra=FELIPE-AVELLO&paso=inicio #FelipeAvello en vivo desde Teatro Nescafé de las Artes 2024 Extractos del show realizado el 29 de agosto del 2024. Si quieres ver este capitulo en video, lo podrás encontrar en nuestro canal de Youtube https://www.youtube.com/@FelipeAvelloOficial Capítulo: https://www.youtube.com/watch?v=ormAF_Oj89g También nos puedes encontrar en: Instagram: https://instagram.com/felipeavellooficial?igshid=MzRlODBiNWFlZA== TikTok: https://www.tiktok.com/@felipeavellooficial?_t=8g1JYWMrkRB&_r=1 Para próximos shows y compra de entradas visita: https://felipeavello.cl/

Unfortunately, there simply isn't a one-size-fits-all treatment protocol for patients infected with Lyme disease and/or co-infections. This is why it's critical for physicians treating Lyme disease to invest time with patients, thoroughly understand their medical history, and closely monitor symptoms and treatment response. With that in mind, there are currently two different treatment approaches for Lyme disease. The Infectious Disease Society of America (IDSA) and the International Lyme and Associated Diseases Society (ILADS) have each published their own set of evidence-based treatment guidelines. IDSA guidelines recommend a short course of antibiotics, typically 14 to 30 days. IDSA argues that the Borrelia burgdorferi bacteria do not persist in a patient beyond this timeframe and that lingering symptoms are the result of an ongoing immune response and not an active infection. It also cites scientific evidence claiming treatments beyond 30 days are ineffective, unnecessary, and even dangerous. IDSA physicians will stop treatment after 30 days, even if symptoms remain. They advise an additional 30 days of treatment recommended for patients with Lyme arthritis.  On the contrary, ILADS offers its own scientific data to show that a additional treatment with antibiotics is required to eradicate the bacteria. ILADS recognizes that a month of treatment may be sufficient for patients in the acute stage of Lyme disease, but in cases where the spirochete has disseminated and the disease has advanced, a 30-day treatment regimen is inadequate. ILADS guidelines recommend additional antibiotics until a patient's symptoms have been resolved. Treating Lyme disease in its advanced stage can be complicated based on the complexity of the organism itself, differences in each patient's immune system, the length of time infected, and the possible presence of other co-infections transmitted by the same tick. There are several choices in treating Lyme disease, which include oral, intravenous, and intramuscular antibiotic options. Other options may include sequential antibiotic therapy, higher doses of antibiotics, taking antibiotics for a longer period of time, a combination of antibiotics, retreatment, as well as diagnosing and treating co-infections. Some specific antibiotics used in treating Lyme disease are doxycycline, minocycline, amoxicillin, cefuroxime, azithromycin, and clarithromycin. Other tests include measures of blood counts, chemistries, liver function tests, ANA, dsDNA, RF, TSH, free T3, free T4, ESR may be helpful at ruling out other conditions.  Referral to specialist might help to rule out other conditions.  I find shared decision with my patient helpful. I also find follow-up helpful to assess my patient's response to treatment to rule out other conditions. There are additional protocols that may also aid in treating Lyme disease, such as avoiding alcohol, simple and processed sugars, exercising as tolerated, counseling for a Jarisch-Herxheimer reaction, managing symptoms, monitoring and reducing the risk of an adverse event, and reducing stress. However, there is a chance of side effects such as Clostridium difficile-associated diarrhea (CDAD). Probiotic have been prescribed with the hope of reducing the risk of developing CDAD.   

65 -Evènementiel et culture du 4 au 11 mars 2024“Journée Internationale des Droits des Femmes”Argelès : conférence sur les femmes artistes le 8 mars à 18h Espace de la GareArrens-Marsous : ciné-débat “We are coming” le 8 mars à 20h30 Maison du Val d'AzunCapvern : Concert “Tyke et les Sweet Cocottes” (collectif "Paroles de Femmes)" le 9 mars à 20h30 Salle BrassensLourdes : Ciné-débat “Peur bleue” (CDAD 65) le 4 mars à 20h30 Palais des CongrèsCiné-rencontre “Une affaire de femmes” le 6 mars à 20h30 cinéma Le PalaisExposition "Femmes sportives d'hier et d'aujourd'hui" du 1 au 9 mars au Palais des Congrès et du 11 au 21 mars au Palais des SportsThéâtre le 8 mars à 14h30 Palais des Congrès “Les Audacieuses du Vignemale”Lecture hommage à Annie Ernaux le 8 mars à 20h30 Palais des Congrèsle 9 mars au Palais des Congrès à 14h chants, à 16h concert partagé, à 17h30 conte, à 18h30 apéro “droits des femmes”Séméac : Ciné CSE et COS “Divertimento” le 8 mars à 20h30 au CACTarbes : tous les évènements Journée des droits des femmes – Site officiel de la Ville de TarbesExposition “Les couleurs pour le dire” de Véronique CLANET du 4 au 10 mars hall de la MairieExposition "Photo-génie" de l'ESAD le 7 mars à 17 H Grand Amphi de l'ENITConcert “DILUVIENNE” ( La Gespe) le 8 mars à 19h MDA Quai de l'Adour Lecture “Je suis une fille sans histoire” le 9 mars à 18h Petit Théâtre Maurice SarrazinEvènements Parc National des Pyrénées"Les Pyrénées secrètes- la discrète du pièmont la genette " , projection-débat le 4 mars à 18 h Maison du Val d'Azun Arrens-Marsous“Les Pyrénées secrètes- le corsaire des cimes le gypaète barbu ”, projection-débat le 6 mars à 18 h Maison du Val d'Azun Arrens-MarsousProjection du film documentaire “Hors piste” à 17h le 5 mars salle des conférences Mairie de St LarySpectacle “A More” Cie HBBB le 5 mars à 19h Maison du Parc National et de la Vallée Luz St Sauveur"Le Printemps des poètes 2024" à St Lary Soulan du 9 au 23 mars à la Maison du Patrimoinele 9 mars à 11h 30 ouverture et remise du prix St Lary de poésie, à 16h vernissage de l'exposition “Le jazz au bout des doigts” de Sophie le Roux et à 18h 30 rencontre-signature avec Jérôme Leroyle 11 mars à 18h30 concert de Jean-Marc Dos SantosConférence "Militer pour la langue occitane, une aventure collective" par Jean-Louis LAVIT, le 8 mars à 18h à la Bourse du Travail de TarbesCafé-Philo le mardi 5 mars 18h45 à l'Echoppe des Galopins Tarbes "Suis-je l'auteur de ma propre vie ?" ( Reliance en Bigorre)Atelier cinéma UTL : le 7 mars à 15h Ciné-Parvis avec “Les triplettes de Belleville”Carte blanche UTL aux associations : association ADT Quart Monde le 6 mars à 17h30 Espace Jeanne LarroqueSpectaclesConcert Vieux Farka Touré au Théâtre des Nouveautés (organisé par la Gespe) le 9 mars 20h30Le Parvis“ De la paille dans la tête”Cie Zou Maï Prod le 5 mars à 20h30 au CAC de Séméac“ Daddy” de Marion Siéfert le 6 mars à 19h au Parvis“BLEU” à l'Espace Robert Hossein de Lourdes le 7 mars 14h30 et 20h30 et au Terminus d'Arreau le 9 mars à 20h30Orchestre National du Capitole et Alexandre THARAUD le 8 mars 19h au ParvisPetit Théâtre de la Gare à Argelès : concert Garcia Lorca avec Pat y Picos le 9 mars 20h30Saison culturelle de Bagnères de Bigorre :'Mariaj en chonsons" Halle aux Grains le 8 mars 20h30Maison du Savoir – St Laurent de Neste :“Le Ciel est par dessus le le toit” le 9 mars à 9h45Salle des fêtes Thermes-Magnoac spectacle "Joséphine Baker" le 9 mars à 15h47° Salon Régional de l'Agriculture du 7 au 10 mars Parc des Expositions TarbesExpositions nouvelles ( Mairie Bordères/Echez, CAC Séméac) et en cours( détails dans le podcast),Autres concerts et cinéma : détails dans podcast

Evènementiel et culture dans le 65 du 26 février au 4 mars 202Evènements Parc National des Pyrénées- Conférence sur le réchauffement climatique et l'érosion de la biodiversité proposée par les gardes moniteurs du Parc National le 26 février à 18 h à la Maison du Parc National et de la Vallée à Luz St Sauveur- "Les Pyrénées secrètes-  le corsaire des cimes le gypaète barbu " , projection-débat le 26 février à 18 h à la Maison du Val d'Azun à Arrens-Marsous- "Les Pyrénées secrètes- le roi des forêts ancestrales l'ours" , projection-débat le 28 février à 16 h à la Maison du Parc National de Cauterets et le 28 février à 18 h à la Maison du Val d'Azun à Arrens-Marsous- Projection et rencontre avec le réalisateur du film documentaire "Le chant du sauvage" à 20h le 29 février  à la Maison du Parc National et de la Vallée de Luz St Sauveur- Projection et rencontre sur le film "Veilleurs de montagne" le 27 février à 17 h à St Lary-Soulan (rue des Fougères)Atelier "Livres et rencontres" organisé par l'UTL-TB  : avec Jean-Louis REY, auteur de "Les porteurs du Pic du Midi de Bigorre" le 26 février à 17h30 à l'Espace Jeanne Larroque (13 rue Blaise Castells ) à TarbesRencontres avec des auteurs- le 27 février à 14h30 à la Médiathèque d'Argeles avec Laëtitia MALTESE, autrice et navigatrice- le 28 février à 10h à la Ludothèque d'Entrée de Jeu avec Marie et Wilfried FORT, auteurs de jeux de sociétéCauserie verte avec Annick BALERI le 2 mars à 9h45 à la médiathèque de Lourdes3° édition du Carnaval Bigourdan de Tarbes le 2 mars à partir de 14h (rdv Place du Foirail) à TarbesSpectacles"ICE"  par la Cie de la Tong en partenariat avec JAZZ PYR le 28 février à 19h à la Maison du Parc National et de la Vallée de Luz St SauveurThéâtre jeune public : détails dans le podcast Pari hors les murs :- "Voix si Voix la Tralala !" par la Cie Les Trimarantes au Petit Théâtre Maurice Sarrazin à Tarbes du 27 février au 3 mars 2024 ( détails podcast) Le Parvis-Théâtre jeune public " BLOCK" le 28 février à 17 h aux Ateliers du Parvis- "INVISIBILI" par la Cie 111 le  26 février à 20h30  et le 27 février à 19 h au Parvis- " De la paille dans la tête" Cie Zou Maï Prod  les 27, 29 février et 1,2,3 et 5 mars dans le département( détails podcast)- " Sans tambour" de Samuel ACHACHE le 1er mars à 20h30 au ParvisMaison du Savoir - St Laurent de Neste :"Ce qu'il en coûte" par la Cie Les attracteurs étranges le 1er mars à 20h30ECLA -Aureilhan : "Papa" par la Cie des Improsteurs le 1er mars à 20h30Centre Albert Camus - Séméac : ciné- conférence-débat autour du film "Peur bleue" proposé par le CDAD 65 le 1er mars à 20h30JAZZ MDA : concert avec le trio Yonathan AVISHAI le 1er mars à 20h30  à la Salle de l'Ensemble Instrumental (1 rue Tristan Derème Tarbes Conservatoire Henri Duparc : concert "Duo Explorer" le 28 février à 20h30 à l'Auditorium Gabriel Fauré TarbesConcert de l'ensemble vocal "Mezza Voce" et du Chœur Franco-Allemand de Toulouse le 3 mars à 17h à la Collégiale St Laurent d'IbosConcert de "Bouillon de Brouches" le 28 février à 20h30 à la Chapelle des Pénitents à Monléon-MagnoacSalon Mets et vins "Bernard Moulet" organisé par le Lions Club de Lourdes du 1 au 3 mars à l'Espace Robert Hossein à Lourdes au profit des malvoyantsExpositions nouvelles (Bibliothèque Esparros, Centre Art Contemporain du Parvis, Maison Parc National Luz St Sauveur, Maison de ma région Tarbes, Agence TLP mobilités Tarbes, Salon Chou Tarbes et BD Vore Tarbes)   et en cours  (tous les détails dans le podcast),  Autres concerts et cinéma : détails dans podcast 

In this episode, we announce the second iteration of the HelixTalk Drug Superlative Awards -- awards given to medications on the market that are outstanding or notorious. In announcing these completely fictitious awards, we review key clinical pearls and pitfalls that every clinician should be aware of with these notable medications. Key Concepts The award for the most unique phase III patient population for a widely used medication goes to … Pneumovax-23 (PPSV-23) for its predecessor versions that were studied in South African novice gold miners. The award for the most misunderstood boxed warning goes to … all of the DOACs (but specifically apixaban and rivaroxaban). In particular, due to BOTH an increased risk of thrombosis and bleeding when switching from a DOAC to warfarin therapy in patients with atrial fibrillation. The award for the biggest difference between pharmacokinetic properties and pharmacodynamic effects goes to … aspirin due to its short-half life and short duration of analgesic effect and yet very prolonged antiplatelet effect. The award for the drug that should be dispensed with extra toilet paper … TIE between irinotecan and clindamycin. The most common dose-limiting adverse effect of irinotecan is diarrhea – loperamide is extensively used in these patients. Clindamycin earns the award because it is the antibiotic most associated with Clostridium difficile-associated diarrhea (CDAD). References Smit P, Oberholzer D, Hayden-Smith S, Koornhof HJ, Hilleman MR. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA. 1977;238(24):2613-2616. Farrar JL, Childs L, Ouattara M, et al. Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults. Pathogens. 2023;12(5):732. Published 2023 May 19. doi:10.3390/pathogens12050732 Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis. Pediatrics. 2009;123(6):e1103-e1110. doi:10.1542/peds.2008-3422 Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Sferra TJ, Hernandez AV, Donskey CJ. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother. 2013 Sep;68(9):1951-61. doi: 10.1093/jac/dkt129.

El editorial de César Vidal. Suscríbete a CesarVidal.TV y escucha este audio antes que nadie y sin publicidad: https://www.cesarvidal.tv Desde los micrófonos del programa La Voz queremos invitar a nuestros oyentes a que escriban a José Lomas Espadas para manifestarle su apoyo y solidaridad a la prisión de Herrera de la Mancha cuya dirección es: Carretera Argamasilla de Alba, s/n, 13200 Manzanares, Cdad. Real, España. Igualmente queremos invitar a los oyentes del programa La Voz para que escriban de la manera más respetuosa a la juez Beatriz Garrido, del juzgado de primera instancia e instrucción número 5 de Ciudad Real: C/ Eras del Cerrillo, 3, 13004 Ciudad Real, España. instándola a poner en libertad a José Lomas Espadas.

Se disputa este domingo (12.00 h) en el Rafael Tapìa Valdés de la Cdad. Dptva. del Centro Excursionista Eldense

Herzlich Willkommen zu einer weiteren Folge im Abschnitt Infektionskrankheiten. In Folge IKH 002 lernen wir etwas über Gasbrand, der meist durch Clostridium perfringens ausgelöst wird, und über die antibiotika-assoziierte Kolitis oder CDAD. Die Kurzzusammenfassung findest du ab ca. Min 24. Viel Spaß beim Zuhören und Lernen ;-) Schreib mir gerne Anregung, Kritik oder einfach nur ein Hallo, auch an die Adresse: tanjaloiblhp@gmail.com. Hier kannst du mich und den Podcast unterstützen: https://steadyhq.com/wissensreise

In episode 57, we had in depth discussion of safety issues, general use and recommendations for PPI therapy. In this episode, we briefly review PPI safety concerns and focus on strategies to deprescribe proton pump inhibitors. Key Concepts PPIs are approved as acid-reducing therapies to treat various conditions related to decreased gastric pH, however, undocumented use of PPI has increased over the years. For indicated conditions, PPI should be used at lowest dose for shortest duration possible. When used for longer than intended duration, PPIs may cause long-term issues such as hypomagnesemia, low vitamin B12 levels, low iron levels, anemia, C. difficile-associated diarrhea (CDAD), chronic kidney disease (CKD), and hypergastrinemia causing rebound acid hypersecretion. Options for limiting PPI use are: abrupt discontinuation, dose reduction, on-demand dosing, slow deprescribing, or switching to alternate therapy. Abrupt discontinuation leads to rebound hypersecretion due to high gastrin levels. There is lack of substantial evidence for what deprescribing strategy is better, but decreasing from multiple times a day to single daily dose, reducing the single daily dose, and switching to every other day are all appropriate strategies. References Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors. Evidence-based clinical practice guideline. Can Fam Physician. 2017 May; 63(5): 354–364. https://deprescribing.org/resources/deprescribing-guidelines-algorithms/ - Specific recommendations for deprescribing certain medications or medication classes

What happens when people need support immediately? Madhavi Reddy of CDAD and Jerry Ann Hebron of Oakland Avenue Urban Farm discuss taking immediate action to serve the needs of communities during times of emergency. Also, Madhavi explains the necessity to streamline funding with Detroit Community Development Mini-Grants, of which Oakland Avenue Urban Farms and Independence Rides are grantees.

Welcome to Episode 5 of 6; of the 8th Annual International C. diff. Post-Conference special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD). We will hear from the following keynote speakers Barbara McGovern, MD, ECOSPORIII: A Phase 3 Double-blind, Randomized, Placebo-controlled Trial of the Efficacy and Safety of SER-109, an Investigational Microbiome Therapeutic for the Treatment of Patients w/Recurrent Clostridioides difficile Infection (rCDI). Glenn Tillotson, Ph.D., FRSM, FCCP, It's a Small World w/C. diff. - a One Health Perspective. Dayle Skelly, C. diff. Survivor, A Patient's Journey. Many of the presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations.

Welcome to Episode 5 of 6; of the 8th Annual International C. diff. Post-Conference special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD). We will hear from the following keynote speakers Barbara McGovern, MD, ECOSPORIII: A Phase 3 Double-blind, Randomized, Placebo-controlled Trial of the Efficacy and Safety of SER-109, an Investigational Microbiome Therapeutic for the Treatment of Patients w/Recurrent Clostridioides difficile Infection (rCDI). Glenn Tillotson, Ph.D., FRSM, FCCP, It's a Small World w/C. diff. - a One Health Perspective. Dayle Skelly, C. diff. Survivor, A Patient's Journey. Many of the presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations.

Welcome to Episode 4 of 6; of the 8th Annual International C. diff. Post-Conference special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD). We will hear from three leading topic-experts: Mark Wilcox, MD, FRCPath, DNA Fingerprinting to Understand C. difficile Transmission in Hospitals. Caterina Oneto, MD, Patient Support; In-Person, and Through the Global TeleSupport Network. Sahil Khanna, MBBS, MD, Microbiome Restoration; Getting One Step Closer Every Day! Many of the presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the leading speakers of the 8th Annual Int'l C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics

Welcome to Episode 4 of 6; of the 8th Annual International C. diff. Post-Conference special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD). We will hear from three leading topic-experts: Mark Wilcox, MD, FRCPath, DNA Fingerprinting to Understand C. difficile Transmission in Hospitals. Caterina Oneto, MD, Patient Support; In-Person, and Through the Global TeleSupport Network. Sahil Khanna, MBBS, MD, Microbiome Restoration; Getting One Step Closer Every Day! Many of the presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the leading speakers of the 8th Annual Int'l C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics

Welcome to Episode 3 of 6; of the 8th Annual Int'l C. diff. Post-Conference special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from three leading topic-experts: Teena Chopra, MD, Introduction to Infection Prevention. David Lyerly, Ph. D., Clostridioides difficile Infection; An Inflammatory Intestinal Disease. Dale Gerding, MD, FACP, FIDSA, Non-toxigenic C. difficile Is Back,. Presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the leading topic-experts ,key note speakers of the 8th Annual Int'l C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics www.summitplc.com

Welcome to Episode 3 of 6; of the 8th Annual Int'l C. diff. Post-Conference special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from three leading topic-experts: Teena Chopra, MD, Introduction to Infection Prevention. David Lyerly, Ph. D., Clostridioides difficile Infection; An Inflammatory Intestinal Disease. Dale Gerding, MD, FACP, FIDSA, Non-toxigenic C. difficile Is Back,. Presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the leading topic-experts ,key note speakers of the 8th Annual Int'l C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics www.summitplc.com

Welcome to Episode 2 of 6; of the 8th Annual Int'l C. diff. Post-Conference Special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from two leading topic-experts and one C. diff. Survivor: Dayle Skelly, C. diff. Survivor A Patient's Journey. Dr. L. Clifford McDonald, MD: Update from the Center for Disease Control and Prevention. Dr. Erik Dubberke, MD, MSPH: Optimizing Prevention of Hospital-Onset Clostridioides difficile. Presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the 8th Annual Int'l C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics www.summitplc.com

Welcome to Episode 2 of 6; of the 8th Annual Int'l C. diff. Post-Conference Special series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative events while focusing on Healthcare-associated infections (HAI), and the leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from two leading topic-experts and one C. diff. Survivor: Dayle Skelly, C. diff. Survivor A Patient's Journey. Dr. L. Clifford McDonald, MD: Update from the Center for Disease Control and Prevention. Dr. Erik Dubberke, MD, MSPH: Optimizing Prevention of Hospital-Onset Clostridioides difficile. Presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the 8th Annual Int'l C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics www.summitplc.com

Welcome to Episode 1 of 6; 8th Annual Int'l C. diff. Post-Conference Special Series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative event possessed while focusing on Healthcare-associated infections (HAI), and a leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from two leading topic-expert, and one C. diff. Survivor: Dr. Paul Feuerstadt C. difficile Infection; Foundation For the Conference. Mrs. Courtney Jones, Developing Next-Generation Microbioe-Based Therapeutics. and Alba Muhlfield, C. diff. Survivor ~ A Patient's Journey. Presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the 8th Annual International C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics www.summitplc.com

Welcome to Episode 1 of 6; 8th Annual Int'l C. diff. Post-Conference Special Series Sponsored by Summit Therapeutics. This year's Live Online Conference had robust dynamics as in leading annual, collaborative event possessed while focusing on Healthcare-associated infections (HAI), and a leading HAI -- Clostridioides difficile (Also known as C. diff., C. difficile, CDI, CDAD) with interconnected topics. In this episode, we will hear from two leading topic-expert, and one C. diff. Survivor: Dr. Paul Feuerstadt C. difficile Infection; Foundation For the Conference. Mrs. Courtney Jones, Developing Next-Generation Microbioe-Based Therapeutics. and Alba Muhlfield, C. diff. Survivor ~ A Patient's Journey. Presentation Slides are available until January 14th, 2021 on www.cdiff2020.com We hope you enjoy the presentations from the 8th Annual International C. diff. Conference & Health EXPO. This audio broadcast is sponsored by Summit Therapeutics www.summitplc.com

La réforme des études en Santé entrera en vigueur en septembre prochain, comment cela fonctionnera-t-il ? Carine Bouix, coordinatrice du CDAD 14 nous parlera d'un nouveau service de cet organisme, accessible directement sur le Campus 1. Qui est Tove Jansson ? Ce sera notre portrait de BU de février. Instant Réflexion.s : Marion Duchesne, doctorante en civilisation espagnole est la cinquième à avoir le compte Instagram de Normandie Université. Sa thèse porte sur le rôle des frères et fils de roi en Espagne au XVIIe siècle. Pauses Musicales : 070 Shake - Guilty Conscience COIN - Youuu Talkie Walkie - All at Once

Clostridium difficile (klos-TRID-e-um dif-uh-SEEL), often called C. difficile or C. diff impacts 453,000 people every year. And with 29,000 associated deaths, it takes more lives than AIDS and drunk-driving combined. Yet, most people have never even heard of it. That's a big problem because you can't protect yourself from a threat when you don't even know it exists. The impact on the business of healthcare is significant too. A study published in the American Journal of Infection Control found that C. diff-associated diarrhea (CDAD) increases hospital costs by 40% per case (an average of $7,285 ) and puts those infected at high risk for longer hospital stays and readmissions.  Some even believe those numbers are likely underestimated. C. diff presents us with an interesting problem at the cross-section of Infection Prevention and Control (IPAC). It's an environmental bacterium that's found pretty much everywhere and is difficult to kill, but it's usually held in check by the good bacteria in our bodies. The problem usually occurs when a patient is in a weakened state from some other healthcare intervention. That may be an antibiotic treatment for another healthcare-associated infection or chemotherapy, etc. With our bodies in a weakened state and our good bacteria depleted by antibiotics, we become susceptible to C. diff. So, it's important that we avoid unnecessary antibiotics and execute on all the other IPAC practices like proper hand hygiene and surface cleaning in the hospital so that, as our guest puts it, we can disrupt the chain of events that allow to C. diff to proliferate.   This episode originally aired on The #HCBiz Show! on April 26th, 2017.   On this episode, we're joined by the co-founder and Executive Director of the Peggy Lillis Foundation (PLF), Christian John Lillis.  Like so many people who've dedicated their lives to driving change in the healthcare industry, Christian has a very powerful “why”. He lost his mother to a clostridium difficile (C. diff) infection in April 2010. After struggling with the fact that he lost his mother to a disease he never heard of, and later finding out that it impacts so many people, Christian, along with his brother Liam, founded PLF and are building a nationwide C. diff awareness movement by educating the public, empowering advocates and shaping policy. Christian gives us a deep and personal take on his family's experience with C. Diff and the work that the Peggy Lillis Foundation is doing to help. We discuss: What is clostridium difficile (C. diff)? Is C. diff a Healthcare-Associated Infection (HAI) or something else? How important are hand hygiene and environmental cleaning in preventing the spread of C. diff? Why haven't more people heard of C. diff? Why is it so hard to measure the true impact of C. diff on our health system? How do we fix that? Why do only some states require reporting on outbreaks? How does that affect the business of healthcare? How does it affect the patients? What is the Prevention and Public Health Fund? Why is it under fire and what is the impact to the CDC, states and beyond? What is the financial impact of C. diff?   Christian's story is powerful and it's full of wisdom that can help patients, families, and providers. In our quest to unravel the business of healthcare, it's important to understand the people we serve and how our work impacts their lives. This is a crash course and I hope it touches you as it did me. Enjoy. For more details visit DeepDive.tips

Join us with our guest, Neal I. Muni, MD, MSPH, President and CEO of CutisPharma as we discuss CutisPharma and their new FDA approved product FIRVANQ ™ Listen in as we learn more about the Company's history, their unique product offerings that help pharmacists compound drugs, and product information for FIRVANQ ™, their recently approved vancomycin oral solution.

Join us with our guest, Neal I. Muni, MD, MSPH, President and CEO of CutisPharma as we discuss CutisPharma and their new FDA approved product FIRVANQ ™ Listen in as we learn more about the Company's history, their unique product offerings that help pharmacists compound drugs, and product information for FIRVANQ ™, their recently approved vancomycin oral solution.

Join us with our guest, Neal I. Muni, MD, MSPH, President and CEO of CutisPharma as we discuss CutisPharma and their new FDA approved product FIRVANQ ™ Listen in as we learn more about the Company's history, their unique product offerings that help pharmacists compound drugs, and product information for FIRVANQ ™, their recently approved vancomycin oral solution.

In this episode, we discuss the efficacy and safety of probiotics for the prevention of antibiotic-associated diarrhea (AAD) and Clostridium difficile-associated diarrhea (CDAD).

Clostridium difficile (klos-TRID-e-um dif-uh-SEEL), often called C. difficile or C. diff impacts 453,000 people every year. And with 29,000 associated deaths, it takes more lives than AIDS and drunk-driving combined. Yet, most people have never even heard of it. That's a big problem because you can't protect yourself from a threat when you don't even know it exists. The impact on the business of healthcare is significant too. A study published in the American Journal of Infection Control found that C. diff-associated diarrhea (CDAD) increases hospital costs by 40% per case (an average of $7,285 ) and puts those infected at high risk for longer hospital stays and readmissions.  Some even believe those numbers are likely underestimated. C. diff presents us with an interesting problem at the cross-section of Infection Prevention and Control (IPAC). It's an environmental bacterium that's found pretty much everywhere and is difficult to kill, but it's usually held in check by the good bacteria in our bodies. The problem usually occurs when a patient is in a weakened state from some other healthcare intervention. That may be an antibiotic treatment for another healthcare-associated infection or chemotherapy, etc. With our bodies in a weakened state and our good bacteria depleted by antibiotics, we become susceptible to C. diff. So, it's important that we execute on all the other IPAC practices like proper hand hygiene and surface cleaning in the hospital so that, as our guest puts it, we can disrupt the chain of events that allow to C. diff to proliferate. Episode 005 (part 4 of our IPAC series): On this episode, we're joined by the co-founder and Executive Director of the Peggy Lillis Foundation (PLF), Christian John Lillis.  Like so many people who've dedicated their lives to driving change in the healthcare industry, Christian has a very powerful "why". He lost his mother to a clostridium difficile (C. diff) infection in April 2010. After struggling with the fact that he lost his mother to a disease he never heard of, and later finding out that it impacts so many people, Christian, along with his brother Liam, founded PLF and are building a nationwide C. diff awareness movement by educating the public, empowering advocates and shaping policy. Christian gives us a deep and personal take on his family's experience with C. Diff and the work that the Peggy Lillis Foundation is doing to help. We discuss: What is clostridium difficile (C. diff)? Is C. diff a Healthcare-Associated Infection (HAI) or something else? How important are hand hygiene and environmental cleaning in preventing the spread of C. diff? Why haven't more people heard of C. diff? Why is it so hard to measure the true impact of C. diff on our health system? How do we fix that? Why do only some states require reporting on outbreaks? How does that affect the business of healthcare? How does it affect the patients? What is the Prevention and Public Health Fund? Why is it under fire and what is the impact to the CDC, states and beyond? What is the financial impact of C. diff? Christian's story is powerful and it's full of wisdom that can help patients, families, and providers. In our quest to unravel the business of healthcare, it's important to understand the people we serve and how our work impacts their lives. This is a crash course and I hope it touches you as it did me. Enjoy. ~Don Lee   About Christian John Lillis Christian John Lillis is executive director of The Peggy Lillis Foundation (PLF), which he co-founded with his brother, Liam, following the death of their mother from a clostridium difficile (C. diff) infection in April 2010. PLF is building a nationwide C. diff awareness movement by educating the public, empowering advocates and shaping policy. He was previously managing director of prospect strategy & research at Teach For America. With more than 15 years' experience as a frontline fundraiser and behind-the-scenes strategist for healthcare, LGBT rights, and education organizations, he led prospect identification and research programs that increased resource development both nationally and regionally. Prior to joining Teach For American in November 2009, Christian served in a variety of roles for a diverse group of nonprofits, including as Director of Development for In The Life Media, Director of Major Gifts for the National LGBTQ Task Force, and Associate Director of Development Research for NYU Langone Medical Center. Throughout his career, Christian has been a frequent speaker at conferences including the Mid-Atlantic Researchers Conference and Creating Change: The National Conference on LGBT Equality. He was also a contributor to Prospect Research: A Primer for Growing Nonprofits by Cecilia Hogan. Christian is an adviser to the Patient Voice Institute and Gulf Coast C. diff Collaborative, as well as a member of Consumers Union Safe Patient Project and Chicago Area Patient-Centered Outcomes Research Network. He is a former member of the board of directors of the Center for Lesbian and Gay Studies at the City University of New York and the Association of Professional Researchers for Advancement (APRA) of Greater New York. Christian began his fundraising career at Lambda Legal Defense & Education Fund. He holds a B.A. in Political Theory from Brooklyn College, where he served as a term as President of the Lesbian, Gay, Bisexual and Transgender Alliance and won The Donald G. Whiteside Poetry Award his senior year. Christian is a native of Brooklyn, New York. He currently lives in Park Slope with his husband, Chris Young, and their rescued “beagle baby”, April. His hobbies include Tae Kwon Do (he is a black belt), Zumba, reading comic books and JD Robb's “In Death” series, and poetry writing. About the Peggy Lillis Foundation Mission: The Peggy Lillis Foundation is building a nationwide clostridium difficile awareness movement by educating the public, empowering advocates, and shaping policy. Vision: We envision a world where C. diff is rare, treatable and survivable. https://peggyfoundation.org/ 2017 C. diff Summit & National Strategy Meeting Facebook: https://www.facebook.com/PeggyFoundation/ Twitter: @PeggyFund Mentioned on the show: The Uncounted: The deadly epidemic America is ignoring. A Reuters report. Catastrophic Care: Why Everything We Think We Know about Health Care Is Wrong: One of my favorite books on healthcare. Be prepared to be jarred and probably angry, but more aware of what's going on in the business of healthcare. Also, a good listen on Audible at 1.25 speed. Patient Mortality During Unannounced Accreditation Surveys at US Hospitals About the Infection Prevention and Control Series This episode is part of The #HCBiz Show's Infection Prevention and Control (IPAC) series. We'd like to thank our partners InfectionControl.tips and the Center of Excellence for Infection Prevention and Control (COE IPAC) for their support and guidance with the series. About InfectionControl.tips InfectionControl.tips is a Pan-Access journal that extends globally and touches locally. www.IC.tips is: Free to Publish. Free to Access and provides Accessible Scientific Services. About Center of Excellence for Infection Prevention and Control (COE IPAC) Center of Excellence for Infection Prevention and Control (COE IPAC) is a collaborative effort to accelerate and support new solutions that hold the promise of significantly advancing infection prevention and control. On a quarterly basis, the Center of Excellence will evaluate at least 3 international innovations – giving them access to independent testing, publication as well as a US commercialization site. The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media.   Soundtrack credit: Acid Lounge by FoolBoyMedia